Medical Technologies announced today that its sensory insoles, analytics platform, and remote monitoring program will be used in a new clinical trial funded by the National Institutes of Health (NIH).
Dr. Khaled Khalaf with Vital Heart & Vein explains how the FDA-approved Rybelsus may help high-risk adults with Type 2 ...
With its new investment, Beacon plans to scale its technology and operations. It aims to accelerate neurobiomarker discovery ...
The disposable single-use devices, which is as discreet as adhesive bandages, is activated simply by placement on the body. The device senses the body and, over a few minutes or an hour, delivers a ...
Diabetes is one of the most common chronic health conditions worldwide.1 Daily management is tough, but one of the biggest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback